Continuous low-dose anti-angiogenic/metronomic chemotherapy: from the research laboratory into the oncologyclinic-Reference-Cited by-同舟云学术

Continuous low-dose anti-angiogenic/metronomic chemotherapy: from the research laboratory into the oncologyclinic

Published:2002-01 Issue:1 Volume:13 Page:12-15
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Kerbel R.S.,Klement G.,Pritchard K.I.,Kamen B.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/13/1/12/19479969/12.pdf

Reference26 articles.

1. Heterogeneity of angiogenesis and blood vessel maturation in human tumors: implications for antiangiogenic tumor therapies;Eberhard;Cancer Res,2000

2. Inhibition of angiogenesis by the antineoplastic agents mitoxantrone and bisantrene;Polverini;Biochem Biophys Res Commun,1986

3. Redefining the target: chemotherapeutics as antiangiogenics;Miller;J Clin Oncol,2001

4. The onset and extent of genomic instability in sporadic colorectal tumor progression;Stoler;Proc Natl Acad Sci USA,1999

5. Inhibition of tumor angiogenesis as a strategy to circumvent acquired resistance to anti-cancer therapeutic agents;Kerbel;Bioessays,1991

Cited by 169 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metronomic chemotherapy and drug repurposing: A paradigm shift in oncology;Heliyon;2024-02

2. Metronomic chemotherapy in cancer treatment: new wine in an old bottle;Theranostics;2024

3. Low-dose metronomic cisplatin as an antiangiogenic and anti-inflammatory strategy for cancer;British Journal of Cancer;2023-12-01

4. Angiogenesis and Lymphangiogenesis in Medulloblastoma Development;Biology;2023-07-21

5. The Intersection of Biomaterials, Tissue Engineering, and Immuno-oncology;Biomaterial Based Approaches to Study the Tumour Microenvironment;2022-12-07